Kantonsspital St.Gallen
login

publications

Paul Martin Putora

title  
 
Glatzer M, Horber D, Montemurro M, Winterhalder R, Inauen R, Berger M, Pestalozzi B, Pederiva S, Pless M, Putora P M. Choice of first line systemic treatment in pancreatic cancer among national experts. Pancreatology 2020; 20 (2020):686-690.
   
Broglie M A, Dulguerov P, Henke G, Siano M, Putora P M, Simon C, Zwahlen D, Huber G, Ballerini G, Beffa L, Giger R, Rothschild S, Negri S V, Elicin O. A Review of Controversial Issues in the Management of Head and Neck Cancer: A Swiss Multidisciplinary and Multi-Institutional Patterns of Care Study-Part 4 (Biomarkers). Front Oncol 2019; 9:1128.
   
den Hollander J, Broglie M A, Henke G, Siano M, Putora P M, Simon C, Zwahlen D, Huber G, Ballerini G, Beffa L, Giger R, Rothschild S, Negri S V, Elicin O. A Review of Controversial Issues in the Management of Head and Neck Cancer: A Swiss Multidisciplinary and Multi-Institutional Patterns of Care Study-Part 1 (Head and Neck Surgery). Front Oncol 2019; 9:1125.
   
Putora P M. Decision Making in Oncology. JCO Clin Cancer Inform 2019; 3:1-2.
   
Siano M, Dulguerov P, Broglie M A, Henke G, Putora P M, Simon C, Zwahlen D, Huber G, Ballerini G, Beffa L, Giger R, Rothschild S, Negri S V, Elicin O. A Review of Controversial Issues in the Management of Head and Neck Cancer: A Swiss Multidisciplinary and Multi-Institutional Patterns of Care Study-Part 3 (Medical Oncology). Front Oncol 2019; 9:1127.
   
Garelli E, Rittmeyer A, Putora P M, Glatzer M, Dressel R, Andreas S. Abscopal effect in lung cancer: three case reports and a concise review. Immunotherapy 2019; 11:1445-1461.
   
Hundsberger T, Schoser B, Leupold D, Rösler K M, Putora P M. Comparison of recent pivotal recommendations for the diagnosis and treatment of late-onset Pompe disease using diagnostic nodes-the Pompe disease burden scale. J Neurol 2019; 266:2010-2017.
   
Putora P M, Glatzer M, De Ruysscher D, Faivre-Finn C, Belderbos J, Besse B, Blackhall F, Califano R, Cappuzzo F, de Marinis F, Dziadiuszko R, Felip E, Früh M, Garrido P, Le Pechoux C, McDonald F, Nestle U, Novello S, Brien M O, Paz Ares L, Peeters S, Pöttgen C, Ramella S, Reck M, Troost E G C, Van Houtte P, Westeel V, Widder J, Mornex F, Slotman B J. Consolidative thoracic radiotherapy in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts. Radiother Oncol 2019; 135:74-77.
   
Panje C, Putora P M, Hundsberger T, Hottinger A F, Roelcke U, Pesce G, Herrmann E, Matter-Walstra K. Impact of treatment decision algorithms on treatment costs in recurrent glioblastoma: a health economic study. Swiss Med Wkly 2019; 149:w20153.
   
Elicin O, Putora P M, Siano M, Broglie M A, Simon C, Zwahlen D, Huber G, Ballerini G, Beffa L, Giger R, Rothschild S, Negri S V, Dulguerov P, Henke G. A Review of Controversial Issues in the Management of Head and Neck Cancer: A Swiss Multidisciplinary and Multi-Institutional Patterns of Care Study-Part 2 (Radiation Oncology). Front Oncol 2019; 9:1126.
   
Steffen T, Putora P M, Hübner M, Gloor B, Lehmann K, Kettelhack C, Adamina M, Peterli R, Schmidt J, Ris F, Glatzer M. Diagnostic Nodes of Patient Selection for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Among Colorectal Cancer Patients: A Swiss National Multicenter Survey. Clin Colorectal Cancer 2019; 18:e335-e342.
   
Scheithauer W, Putora P M, Grünberger B, Eisterer W, Wöll E, Prager G, Schaberl-Moser R, Greil R, Glatzer M. Patterns of care in metastatic pancreatic cancer: patient selection in clinical routine. Therap Adv Gastroenterol 2019; 12:1756284819877635.
   
Putora P M, Glatzer M, Belderbos J, Besse B, Blackhall F, Califano R, Cappuzzo F, de Marinis F, Dziadziuszko R, Felip E, Faivre-Finn C, Früh M, Garrido P, Le Pechoux C, McDonald F, Nestle U, Novello S, O'Brien M, Paz Ares L, Peeters S, Pöttgen C, Ramella S, Reck M, Slotman B, Troost E G C, Van Houtte P, Westeel V, Widder J, Mornex F, De Ruysscher D. Prophylactic cranial irradiation in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts. Radiother Oncol 2019; 133:163-166.
   
Panje C, Zilli T, Pra A D, Arnold W, Brouwer K, Garcia Schüler H I, Gomez S, Herrera F, Khanfir K, Papachristofilou A, Pesce G, Reuter C, Vees H, Zwahlen D, Putora P M. Radiotherapy for pelvic nodal recurrences after radical prostatectomy: patient selection in clinical practice. Radiat Oncol 2019; 14:177.
   
Putora P M, Glatzer M, De Ruysscher D, Faivre-Finn C, Belderbos J, Besse B, Blackhall F, Califano R, Cappuzzo F, de Marinis F, Dziadiuszko R, Felip E, Früh M, Garrido P, Le Pechoux C, McDonald F, Nestle U, Novello S, O' Brien M, Paz Ares L, Peeters S, Pöttgen C, Ramella S, Reck M, Troost E G C, Van Houtte P, Westeel V, Widder J, Mornex F, Slotman B J. Erratum to "Consolidative thoracic radiotherapy in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts" [Radiother. Oncol. 135 (2019) 74-77]. Radiother Oncol 2019; 141:332.
   
Schlachter M, Raidou R, Muren L, Preim B, Putora P M, Bühler K. State-of-the-Art Report: Visual Computing in Radiation Therapy Planning. Computer Graphics Forum 2019;753-779.
   
Putora P M, De Ruysscher D, Glatzer M, Widder J, Van Houtte P, Troost E G C, Slotman B J, Ramella S, Pöttgen C, Peeters S, Nestle U, McDonald F, Le Pechoux C, Dziadziuszko R, Belderbos J, Faivre-Finn C. The role of postoperative thoracic radiotherapy and prophylactic cranial irradiation in early stage small cell lung cancer: Patient selection among ESTRO experts. Radiother Oncol 2019; 145:45-48.
   
Maas O, Forrer F, Maas M, Panje C, Blautzik J, Brühlmeier M, Engel-Bicik I, Giovanella L, Haldemann A, Kamel M E, Kneifel S, Rottenburger C, Schaefer N, Walter M A, Weidner S, Putora P M. Variations in radioiodine ablation: decision-making after total thyroidectomy. Eur J Nucl Med Mol Imaging 2019;.
   
Glatzer M, Panje C, Sirén C, Cihoric N, Putora P M. Decision Making Criteria in Oncology. Oncology 2018;1-9.
   
Putora P M. Electronic Patient-Reported Outcomes: A New Standard of Care?. Oncology 2018;1-2.
   
Süveg K, Putora P M, Berghmans T, Glatzer M, Kovac V, Cihoric N. Current efforts in research of pleural mesothelioma-An analysis of the ClinicalTrials.gov registry. Lung Cancer 2018; 124:12-18.
   
Glatzer M, Putora P M. Der Einsatz der Radiotherapie beim kleinzelligen Lungenkarzinom: Update 2018. Schweizer Zeitschrift für Onkologie (SZO) 2018; 1:11-13.
   
Glatzer M, Panje C, Siren C, Cihoric N, Putora P M. Decision Making Criteria in Oncology. Oncology 2018; Sep 18:1-9:.
   
Rich A, Baldwin D, Alfageme I, Beckett P, Berghmans T, Brincat S, Burghuber O, Corlateanu A, Cufer T, Damhuis R, Danila E, Domagala-Kulawik J, Elia S, Gaga M, Goksel T, Grigoriu B, Hillerdal G, Huber R M, Jakobsen E, Jonsson S, Jovanovic D, Kavcova E, Konsoulova A, Laisaar T, Makitaro R, Mehic B, Milroy R, Moldvay J, Morgan R, Nanushi M, Paesmans M, Putora P M, Samarzija M, Scherpereel A, Schlesser M, Sculier J P, Skrickova J, Sotto-Mayor R, Strand T E, Van Schil P, Blum T G. Achieving Thoracic Oncology data collection in Europe: a precursor study in 35 Countries. BMC Cancer 2018; 18:1144.
   
Panje C, Glatzer M, Sirén C, Plasswilm L, Putora P M. Treatment Options in Oncology. JCO Clin Cancer Inform 2018; 2:1-10.
   
Zumstein V, Betschart P, Abt D, Schmid H P, Panje C, Putora P M. Surgical management of urolithiasis - a systematic analysis of available guidelines. BMC Urology 2018;.
   
Radovic M, Kanesvaran R, Rittmeyer A, Früh M, Minervini F, Glatzer M, Putora P M. Multidisciplinary treatment of lung cancer in older patients: A review. J Geriatr Oncol 2018; 10:405-410.
   
Nestle U, De Ruysscher D, Ricardi U, Geets X, Belderbos J, Pöttgen C, Dziadiuszko R, Peeters S, Lievens Y, Hurkmans C, Slotman B, Ramella S, Faivre-Finn C, McDonald F, Manapov F, Putora P M, LePéchoux C, Van Houtte P. ESTRO ACROP guidelines for target volume definition in the treatment of locally advanced non-small cell lung cancer. Radiother Oncol 2018; 127:1-5.
   
Putora P M, Markman M. Introduction to the New Section "Oncology and Informatics". Oncology 2018;1.
   
Rich A L, Baldwin D R, Beckett P, Berghmans T, Boyd J, Faivre-Finn C, Galateau-Salle F, Gamarra F, Grigoriu B, Hansen N C, Hardavella G, Jakobsen E, Jovanovic D, Konsoulova A, Massard G, McPhelim J, Meert A P, Milroy R, Mutti L, Paesmans M, Peake M D, Putora P M, de Ruysscher D, Sculier J P, Schepereel A, Subotic D, Van Schil P, Blum T G. ERS Statement on harmonised standards for lung cancer registration and lung cancer services in Europe. Eur Respir J 2018;.
   
Ghadjar P, Hayoz S, Bernhard J, Zwahlen D R, Stein J, Hölscher T, Gut P, Polat B, Hildebrandt G, Müller A C, Putora P M, Papachristofilou A, Schär C, Dal Pra A, Biaggi Rudolf C, Wust P, Aebersold D M, Thalmann G N, Swiss Group for Clinical Cancer Research (SAKK) . Impact of dose intensified salvage radiation therapy on urinary continence recovery after radical prostatectomy: Results of the randomized trial SAKK 09/10. Radiother Oncol 2017;.
   
Ghadjar P, Hayoz S, Genitsch V, Zwahlen D R, Hölscher T, Gut P, Guckenberger M, Hildebrandt G, Müller A C, Putora P M, Papachristofilou A, Stalder L, Biaggi-Rudolf C, Sumila M, Kranzbühler H, Najafi Y, Ost P, Azinwi N C, Reuter C, Bodis S, Khanfir K, Budach V, Aebersold D M, Thalmann G N, Swiss Group for Clinical Cancer Research (SAKK) . Importance and outcome relevance of central pathology review in prostatectomy specimens: data from the SAKK 09/10 randomized trial on prostate cancer. BJU Int 2017; 120:E45-E51.
   
Rothermundt C, Fischer G, Bauer S, Blay J Y, Grünwald V, Italiano A, Kasper B, Kollár A, Lindner L H, Miah A, Sleijfer S, Stacchiotti S, Putora P M. Pre- and Postoperative Chemotherapy in Localized Extremity Soft Tissue Sarcoma: A European Organization for Research and Treatment of Cancer Expert Survey. Oncologist 2017;.
   
Panje C, Glatzer M, von Rappard J, Rothermundt C, Hundsberger T, Zumstein V, Plasswilm L, Putora P M. Applied Swarm-based medicine: collecting decision trees for patterns of algorithms analysis. BMC Med Res Methodol 2017; 17:123.
   
Glatzer M, Schmid S, Radovic M, Früh M, Putora P M. The role of radiation therapy in the management of small cell lung cancer. Breathe (Sheff) 2017; 13:e87-e94.
   
Putora P M, Schmid H P. Oligometastasiertes Prostatakarzinom. Aktuelle Entwicklungen in der Urologie und Radioonkologie. Leading Opinions Hämatol Onkol 2017; 13:58-60.
   
Glatzer M, Rittmeyer A, Müller J, Opitz I, Papachristofilou A, Psallidas I, Früh M, Born D, Putora P M. Treatment of limited disease small cell lung cancer: the multidisciplinary team. Eur Respir J 2017; 50:.
   
Warschkow R, Gueller U, Cerny T, Schmied B, Plasswilm L, Putora P M. Secondary malignancies after rectal cancer resection with and without radiation therapy: A propensity-adjusted, population-based SEER analysis. Radiother Oncol 2017; 123:139-146.
   
Dal Pra A, Panje C, Zilli T, Arnold W, Brouwer K, Garcia H, Glatzer M, Gomez S, Herrera F, Kaouthar K, Papachristofilou A, Pesce G, Reuter C, Vees H, Zwahlen D R, Engeler D, Putora P M. Salvage radiotherapy for macroscopic local recurrences after radical prostatectomy : A national survey on patterns of practice. Strahlenther Onkol 2017; 194:9-16.
   
Hundsberger T, Hottinger A F, Roelcke U, Roth P, Migliorini D, Dietrich P Y, Conen K, Pesce G, Hermann E, Pica A, Gross M W, Brügge D, Plasswilm L, Weller M, Putora P M. Patterns of care in recurrent glioblastoma in Switzerland: a multicentre national approach based on diagnostic nodes. J Neurooncol 2016; 126:175-183.
   
Müller J, Putora P M, Schneider T, Zeisel C, Brutsche M, Bartz-Batliner M, Markus A, Kick J. Handheld single photon emission computed tomography (handheld SPECT) navigated video-assisted thoracoscopic surgery of computer tomography-guided radioactively marked pulmonary lesions. Interact Cardiovasc Thorac Surg 2016; 23:345-350.
   
Bertolini R, Meyenberger C, Putora P M, Albrecht F, Broglie Däppen M, Stöckli S, Sulz M. Endoscopic dilation of complete oesophageal obstructions with a combined antegrade-retrograde rendezvous technique. World J Gastroenterol 2016; 22:2366-72.
   
Putora P M, Engeler D S, Haile S, Graf N, Buchauer K, Schmid H P, Plasswilm L. Erectile function following brachytherapy, external beam radiotherapy, or radical prostatectomy in prostate cancer patients. Strahlenther Onkol 2016; 192:182-9.
   
Rothermundt C, von Rappard J, Eisen T, Escudier B, Grünwald V, Larkin J, McDermott D, Oldenburg J, Porta C, Rini B, Schmidinger M, Sternberg C N, Putora P M. Second-line treatment for metastatic clear cell renal cell cancer: experts' consensus algorithms. World J Urol 2016;.
   
Putora P M, Szentesi K, Glatzer M, Rodriguez R, Müller J, Baty F, Früh M. SUVmax and Tumour Location in PET-CT Predict Oncogene Status in Lung Cancer. Oncol Res Treat 2016; 39:681-686.
   
Glatzer M, Putora P M, Plasswilm L. Radioimmuntherapie – die neue Strategie im Kampf gegen Krebs? Wirkprinzipien, Therapiekonzepte und (prä-)klinische Studiendaten. SZO 2016;.
   
Glatzer M, Elicin O, Ramella S, Nestle U, Putora P M. Radio(chemo)therapy in locally advanced nonsmall cell lung cancer. Eur Respir Rev 2016; 25:65-70.
   
Rothermundt C, Bailey A, Cerbone L, Eisen T, Escudier B, Gillessen Sommer S, Grünwald V, Larkin J, McDermott D, Oldenburg J, Porta C, Rini B, Schmidinger M, Sternberg C, Putora P M. Algorithms in the First-Line Treatment of Metastatic Clear Cell Renal Cell Carcinoma-Analysis Using Diagnostic Nodes. Oncologist 2015; 20:1028-35.
   
Panje C, Dal Pra A, Zilli T, R Zwahlen D, Papachristofilou A, Herrera F G, Matzinger O, Plasswilm L, Putora P M. Consensus and differences in primary radiotherapy for localized and locally advanced prostate cancer in Switzerland: A survey on patterns of practice. Strahlenther Onkol 2015; 191:778-86.
   
Panje C, Panje T, Putora P M, Kim S K, haile s, Aebersold D M, Plasswilm L. Guidance of treatment decisions in risk-adapted primary radiotherapy for prostate cancer using multiparametric magnetic resonance imaging: a single center experience. Radiat Oncol 2015; 10:47.
   
Putora P M, Engeler D S, Haile S R, Graf N, Buchauer K, Schmid H P, Plasswilm L. Erectile function following brachytherapy, external beam radiotherapy, or radical prostatectomy in prostate cancer patients. Strahlenther Onkol 2015; 192:182-9.
   
Plasswilm L, Schmid H P, Schwab C, Putora P M. (Neo-) Adjuvante endokrine Therapie des lokoregionär begrenzten Prostatakarzinoms. J Urol Urogynäkol 2015; 22:10-5.
   
Putora P M, Ess S, Panje C, Hundsberger T, van Leyen K, Plasswilm L, Früh M. Prognostic significance of histology after resection of brain metastases and whole brain radiotherapy in non-small cell lung cancer (NSCLC). Clin Exp Metastasis 2015; 32:143-9.
   
Engeler D S, Schwab C, Thöni A F, Hochreiter W, Prikler L, Suter S, Stucki P, Schiefer J, Plasswilm L, Schmid H P, Putora P M. PSA bounce after (125)I-brachytherapy for prostate cancer as a favorable prognosticator. Strahlenther Onkol 2015; 191:787-791.
   
Glatzer M, Putora P M. Radiochemotherapie beim lokal fortgeschrittenen NSCLC - Update 2015. SZO 2015; 4:18-22.
   
Engeler D S, Schwab C, Thöni A, Hochreiter W, Prikler L, Suter S, Stucki P, Schiefer J, Plasswilm L, Schmid H P, Putora P M. PSA bounce after 125J-brachytherapy for prostate cancer as a favorable prognosticator. Strahlenther Onkol 2015; 191:787-91.
   
Engeler D S, Putora P M, Schmid H P, Aebersold D. Permanente interstitielle Brachytherapie mit Jod-125. info@onkologie 2015; 5:13-5.
   
Putora P M, Panje C, Papachristofilou A, Pra A, Hundsberger T, Plasswilm L. Objective consensus from decision trees. Radiat Oncol 2014; 9:270.
   
Hundsberger T, Tonder M, Hottinger A, Brügge D, Roelcke U, Putora P M, Stupp R, Weller M. Clinical management and outcome of histologically verified adult brainstem gliomas in Switzerland: a retrospective analysis of 21 patients. J Neurooncol 2014; 118:321-328.
   
Putora P M, Oldenburg J. The Kafkaesque process of cancer diagnosis. J Clin Oncol 2014; 32:1087-8.
   
Blum T G, Rich A, Baldwin D, Beckett P, De Ruysscher D, Faivre-Finn C, Gaga M, Gamarra F, Grigoriu B, Hansen N C G, Hubbard R, Huber R M, Jakobsen E, Jovanovic D, Konsoulova A, Kollmeier J, Massard G, McPhelim J, Meert A P, Milroy R, Paesmans M, Peake M, Putora P M, Scherpereel A, Schönfeld N, Sitter H, Skaug K, Spiro S, Strand T E, Taright S, Thomas M, van Schil P E, Vansteenkiste J F, Wiewrodt R, Sculier J P. The European initiative for quality management in lung cancer care. Eur Respir J 2014; 43:1254-77.
   
Putora P M, Früh M, Müller J. FDG-PET SUV-max values do not correlate with epidermal growth factor receptor mutation status in lung adenocarcinoma. Respirology 2013; 18:734-5.
   
Baty F, Putora P M, Isenring B, Blum T, Brutsche M. Comorbidities and Burden of COPD: A Population Based Case-Control Study. PLoS ONE 2013; 8:e63285.
   
Hundsberger T, Brügge D, Putora P M, Weder P, Weber J, Plasswilm L. Re-irradiation with and without bevacizumab as salvage therapy for recurrent or progressive high-grade gliomas. J Neurooncol 2013; 112:133-9.
   
Putora P M, Oldenburg J. Swarm-based medicine. J Med Internet Res 2013; 15:e207.
   
Putora P M, Müller J, Borovicka J, Plasswilm L, Schmidt F. Relevance of incidental colorectal FDG-PET/CT-enhanced lesions. Onkologie 2013; 36:200-4.
   
Putora P M, Schmücking M, Aebersold D, Plasswilm L. Compensability index for compensation radiotherapy after treatment interruptions. Radiation Oncology 2012; 2012:208.
   
preusser s, Putora P M, Plasswilm L, Schmid H P. Castration-resistant prostate cancer : Surgical and radio-oncological therapeutic options. Der Urologe 2012; 51:27-31.
   
Rothermundt C, Putora P M. DESO St. Gallen, 2012: die Therapie des metastasierten Weichteilsarkoms im Erwachsenenalter. Leading Opinions Hämatologie & Onkologie 2012; 2012:1-5.
   
cerny t, Rothermundt C, Putora P M. Palliative Systemtherapie des metastasierten Weichteil-Sarkoms. info@onkologie 2012; 2012:6-9.
   
Putora P M, Schmuecking M, Aebersold D, Plasswilm L. Compensability index for compensation radiotherapy after treatment interruptions. Radiat Oncol 2012; 7:208.
   
Putora P M, horstkemper r, Plasswilm L. Palliative Radiotherapie beim NSCLC: Indikationen und Verfahren. Schweizerische Zeitschrift für Onkologie 2012; 1:12-16.
   
schallegger k, preusser s, Putora P M. Lokale palliative Therapieoptionen beim Prostatakarzinom: Interdisziplinäres Vorgehen bei Schmerzen, infravesikaler Obstruktion, Blutung und therapiebedingten Nebenwirkungen. Schweizerische Zeitschrift für Onkologie 2012; 2012:33-36.
   
Putora P M, Schneider T, Rodriguez R, Früh M. Targeted therapy in non-small cell lung cancer. Breathe 2012; 8:206-215.
   
Keller S, Putora P M, Rothermundt C. Interdisziplinäre Therapie der Extremitäten-Weichteil-Sarkome. info@onkologie 2012; 2012:10-13.
   
Putora P M, Früh M. The place of radiotherapy in the palliative management of NSCLC. Breathe 2011; 8: 134-143 2011;.
   
Putora P M, Benz G, Rodriguez R, Brutsche M, Früh M. Tracheal granuloma pyogenicum with erlotinib treatment for lung cancer. Eur Respir J 2011; 38:1228-30.
   
schmidt f, Cathomas R, Stallmach T, Putora P M, Müller J. Have you ever heard of hibernoma? A rare but important pitfall in FDG-PET/CT. Nuklearmedizin 2010; 49:N71-3.
   
Putora P M, Paulis L, Plasswilm L. Automated Erythema Quantification in Radiation Therapy - a Java Based Tool. Applied Medical Informatics 2010; 26:1-6.
   
Putora P M, Blattner M, Papachristofilou A, Mariotti F, Paoli B, Plasswilm L. Dodes (diagnostic nodes) for Guideline Manipulation. Journal of Radiation Oncology Informatics 2010; 2:1-8.
   
Putora P M, Plasswilm L, Paulis L. Automated contrast painting for position verification in radiotherapy. Journal of Radiation Oncology Informatics 2009; 1:23-29.
   
Urban S, Putora P M. Smoking habits of medical students in Bratislava, Slovak Republic. Bratislavské lekárske listy 2009; 110:582.
   
Elicin O, Schmücking M, Bromme J, Rauch D, Ambarcioglu P, Plasswilm L, Geretschlager A, Ghadjar P, Giger R, Aebersold D M. Volumetric regression ratio of the primary tumor and metastatic lymph nodes after induction chemotherapy predicts overall survival in head and neck squamous cell carcinoma: a retrospective analysis. J BUON 21:175-81.
   
Früh M, Baty F, Putora P M, & Brutsche M (2011). Advances in Personalized Cancer Management. In Advances in Personalized Cancer Management (pp. 58-67). London: Future Medicine Ltd.
   
Glatzer M, Putora P M, Müller J, Minervini F, & Plasswilm L (2016). Case report: radio-supersensitive oligometastatic lung cancer. In .
   
Putora P M, fornaro j, Devecka M, Duma M, & Plasswilm L (2012). Customized Lung Phantom for Internal Target Volume Evaluation. In (pp. 152): SASRO.
   
Duma M, Devecka M, Berndt J, Oechser M, & Putora P M (2012). Motion Artifacts and Implications of Different Window Levels in Contouring of Moving Targets. In SASRO 2012 (pp. 56): SASRO.
   
horstkemper r, Putora P M, toepfer m, & Plasswilm L (2012). Good Reponse of Palliative Radiotherapy for Very Advanced Metastastic Melanoma. In (pp. 100).
   
Putora P M, horstkemper r, Müller J, & Plasswilm L (2012). Radiotherapy with 3Gy for Inflammation due to Heterotopic Ossifications. In (pp. 117): SASRO 2012.
   
Putora P M, horstkemper r, Papachristofilou A, & Plasswilm L (2012). Manipulation and Quality Assurance of Guidelines; an Online Implementation of Diagnostic Nodes (Dodes). In (pp. 116): SASRO.
   
Collon J, Schiefer J, stolz a, naef g, Putora P M, schneider m, Fretz C, & Plasswilm L (2011). A Training Method for Prostate Delineation Based on CT- and MR-Images. In SASRO 2011 final program (pp. 102).
   
stolz a, Schiefer J, Collon J, naef g, Putora P M, seelentag w, & Plasswilm L (2011). Can the Number of Cone Beam CTs be Reduced Based on the Patient Displacements Applied in the first Therapy Week?. In SASRO 2011 final program (pp. 103).
   
Putora P M, Brügge D, schmidt f, Engeler D S, Müller J, & Plasswilm L (2011). Postoperative Prostate Radiotherapy: Did we need Bone Scans?. In SASRO 2011 final program (pp. 100).
   
Engeler D S, Putora P M, Plasswilm L, seelentag w, Schiefer J, & Schmid H P (2011). Reimplantation nach insuffizienter primärer I-125 LDR-Brachytherapie beim Prostatakarzinom. In Der Urologe, Supplement 1, 2011, p. 13.
   
Brügge D, Putora P M, Engeler D S, Müller J, schmidt f, & Plasswilm L (2011). SPECT-CT, Cholin-PET-CT, MRI and CT for Diagnosis of Prostate Cancer in the Prostate Bed, Regional Lymph Node and Bone Lesion. In SASRO 2011 final programm (pp. 99).
   
Brügge D, Putora P M, Hundsberger T, Weder P, van Leyen K, & Plasswilm L (2011). Re-Irradiation with Bevacizumab in Recurrent Malignant Gliomas. In SASRO 2011 final program (pp. 101).
   
Putora P M, fornaro j, Schiefer J, Brügge D, & Plasswilm L (2011). Radiotherapy Treatment Interruption Compensation Calculator for Android Based Mobile Devices. In SASRO 2011 final programm (pp. 16).
   
toepfer m, Wille N, Putora P M, Brügge D, Arn M, Schiefer J, & Plasswilm L (2010). Patterns of Failure and Toxicity after Intensity-Modulated Radiotherapy with Simultaneous Integrated Boost for Head and Neck Cancer. In Final Program SASRO 2010 (pp. 44). Bern: SASRO.
   
Putora P M, Baty F, Ludwig P, Rogenmoser G, Plasswilm L, & Brutsche M (2010). The Influence of Malignancy and Referring Department on Smoking Cessation Success. In Journal of Thoracic Oncology 5:5 May 2010 (pp. 53): WK, LWW.
   
Putora P M, schmidt f, stolz a, Müller J, & Plasswilm L (2010). The Necessity for Workup of Incidental Colon FDG Lesions in PET-CT During Staging. In Strahlentherapie und Onkologie 2010;186 (Sondernr 1):22 (pp. 22). München: Springer / Urban&Vogel.
   
 
page 1 of 2